Specialties
Cartilage Repair
Specialties
Hip
Specialties
Orthopaedics
175 results found in 5ms
Questions to ask before a ChondroFiller injectionQuestions to ask before a ChondroFiller injection
ChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.ChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.
ChondroFiller repeat injections and long-term repairChondroFiller repeat injections and long-term repair
ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.
When cartilage repair is the right choiceWhen cartilage repair is the right choice
Cartilage repair is suited to younger, active patients with isolated damage in otherwise healthy joints where conservative care has not worked. It is mechanistically impossible when underlying bone is worn smooth, degeneration spans multiple compartments, or malalignment and instability persist uncorrected.Cartilage repair is suited to younger, active patients with isolated damage in otherwise healthy joints where conservative care has not worked. It is mechanistically impossible when underlying bone is worn smooth, degeneration spans multiple compartments, or malalignment and instability persist uncorrected.
Physiotherapist or surgeon first for a meniscus tearPhysiotherapist or surgeon first for a meniscus tear
For most meniscus tears, physiotherapy is the evidence-supported first step; surgery is reserved for lockedknees, persistent instability, or severe acute injuries that fail to settle.For most meniscus tears, physiotherapy is the evidence-supported first step; surgery is reserved for locked knees, persistent instability, or severe acute injuries that fail to settle.
ChondroFiller Injection Evidence Patients Should WeighChondroFiller Injection Evidence Patients Should Weigh
Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.
ChondroFiller™ durability compared with ArthrosamidChondroFiller™ durability compared with Arthrosamid
ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.
Who qualifies for ChondroFiller injectionWho qualifies for ChondroFiller injection
ChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.ChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.
Ten-Year Success Rates for OATS MosaicplastyTen-Year Success Rates for OATS Mosaicplasty
Ten-year success rates for OATS mosaicplasty span 72–89% in young, active patients; failure rates drop to 12.5–14% in optimal candidates (under 40, lesion under 3 cm²) but rise to 38–40% in older patients with larger defects.Ten-year success rates for OATS mosaicplasty span 72–89% in young, active patients; failure rates drop to 12.5–14% in optimal candidates (under 40, lesion under 3 cm²) but rise to 38–40% in older patients with larger defects.
175 results found in 5ms